GPR162 modulators (neuropsychiatric disorders)

BAY-55-8800

dopamine receptor modulators (neuropsychiatric diseases)

SGE-516

Kv7 potassium channel openers (epilepsy/pain/neuropsychiatric disorders)

dopamine pathway modulator (drug combination, neuropsychiatric/ neurodegenerative disease)

cannabinoid therapy (oral controlled release formulation/oral patch, neuropsychiatric disorder)

Cytidine

C₉H₁₃N₃O₅

Uridine

C₉H₁₂N₂O₆

Dexbrompheniramine(Ala-hist Ir, Ala-hist PE, Dologen, Dologesic Reformulated Jun 2016)

C₁₆H₁₉BrN₂